Trial Details 10 Total Sites

Dociparstat (DSTAT) in Combination With Standard Chemotherapy for the Treatment of Acute Myeloid Leukemia (AML) (DASH AML)

Phase 3 study to evaluate the efficacy and safety of dociparstat sodium in adults with newly diagnosed untreated AML with adverse or intermediate genetic risk.

New York City, New York
facility
Mount Sanai School of Medicine
1 facility
Recruiting
Dallas, Texas
facility
Baylor
1 facility
Recruiting
New Orleans, Louisiana
facility
Tulane University School of Medicine
1 facility
Recruiting
Louisville, Kentucky
facility
Norton Cancer Institute, St. Matthews Campus
1 facility
Recruiting
Salt Lake City, Utah
facility
University of Utah / Huntsman Cancer Institute
1 facility
Recruiting
Orange, California
facility
UC Irvine Medical Center
1 facility
Recruiting
Canton, Ohio
facility
Gabrail Cancer Center
1 facility
Recruiting
Charlottesville, Virginia
facility
University of Virginia Cancer Center
1 facility
Recruiting
Hawthorne, New York
facility
New York Medical College
1 facility
Recruiting
Westwood, Kansas
facility
University of Kansas Cancer Center
1 facility
Recruiting